Synageva BioPharma Corp (NASDAQ:GEVA)

76.97
Data as of Oct 24
 +0.88 / +1.16%
Today’s Change
44.54
Today|||52-Week Range
119.42
+18.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.6B

Company Description

Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1996 and is headquartered in Lexington, MA.

Contact Information

Synageva BioPharma Corp.
33 Hayden Avenue
Lexington Massachusetts 02421
P:(781) 357-9900
Investor Relations:
(781) 357-9947

Employees

Shareholders

Mutual fund holders60.11%
Other institutional42.06%
Individual stakeholders41.77%

Top Executives

Sanj K. PatelPresident, Chief Executive Officer & Director
Robert B. BazemoreChief Operating Officer
Carsten BoessChief Financial Officer & Senior Vice President
Anthony G. QuinnChief Medical Officer & Executive Vice President
Glen WilliamsSenior VP-Global Technical Operations & Quality

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.